Story perspectives
Controversial Puberty-Blocker Trial for Children Set to Begin
12/18/2025
38 5
1 of 1
Story summary
- Health Secretary Wes Streeting says children cannot consent to participate in a puberty-blocker trial and must have informed assent plus parental consent.
- He says the trial is uncomfortable but necessary based on clinical advice from the Cass Review.
- Trial involves over 220 children with gender dysphoria and begins in January to address evidence gaps.
- Critics, including MP Dr. Caroline Johnson, raise concerns about ethics of puberty blockers on healthy children.
